Publications for Mitchell S. Cairo mitchell_cairo@nymc.edu

Abikoff, C. A., Nash, M., Nickerson, B., Harrison, L., Shi, Q., Zhang, X., . . . Cairo, M. S. (2016). A pilot study of unrelated cord blood (UCB) transplantation followed by unmatched human placental derived stem cells (HPDSC) in children and young adults with malignant and non-malignant diseases. Pediatric Blood & Cancer, 63(Suppl S1), S96. doi:10.1002/pbc.25998

Awasthi, A., Ayello, J., van de Ven, C., Chakraborty, S., Barth, M., & Cairo, M. (2016). Polatuzumab vedotin (PV, ANTI-CD79B-VC-MMAE) significantly increased apoptosis/reduced cell proliferation and improved survival against Burkitt lymphoma (BL) and primary mediastinal large B-cell lymphoma (PMBL). Pediatric Blood & Cancer, 63(Suppl 3), S208. This material can be found here.

Awasthi, A., Ayello, J., van de Ven, C., Love, A. C., & Cairo, M. S. (2016). Polatuzumab vedotin; antibody drug conjugates (ADC, anti-CD79b-vc-MMAE, PV) significantly enhances in-vitro cell death against CD79b+ Burkitt lymphoma (BL) /primary mediastinal large B cell lymphoma (PMBL) and improved overall survival against rituximab sensitive/resistant-BL NSG xenograft mice. Blood, 128(22), 4126. This material can be found here.

Ayello, J., Chu, Y., Keever-Taylor, C. A., Talano, J. A., Weinberg, R., Abikoff, C. M.,. . . Cairo, M. S. (2016). A pilot trial of unmatched human placenta-derived stem cells (HPDSCs) in conjunction with unrelated cord blood transplantation (UCBT) in children and young adults with malignant and non-malignant disease (IND 14949). Blood, 128(22), 4671.

Ayello, J., Chu, Y., Keever-Taylor, C. A., Talano, J. A., Weinberg, R., Abikoff, C. M., . . . Cairo, M. S. (2016). Familial haploidentical (FHI) allogeneic stem cell transplantation utilizing CD34 enrichment and T cell addback in children, adolescents & adults with high-risk sickle cell disease. Rapid engraftment, low incidence of AGVHD, and sustained donor chimerism. Blood, 128(22), 1245. 

Ayello, J., Keever-Taylor, C., Weinberg, R., Grossman, B. J., Shenoy, S., Talano, J. X., . . . Cairo, M. (2016). Processing of G-CSF mobilized peripheral blood stem cells (PBSC) from parental haploidentical sickle cell trait donors undergoing CD34 enrichment with T cell addback in children, adolescents and adults with high risk sickle cell disease (IND 14359). Transfusion, 56(S4), 5A.

Barth, M., Goldman, S., Oesterheld, J., Heym, K., Harrison, L., Nickerson, B., & Cairo, M. (2016). Preliminary results of the Reduced Burden of Oncologic Therapy (Reboot) trial in children, adolescents and young adults with intermediate and high risk aggressive B-cell non Hodgkin lymphoma. Pediatric Blood & Cancer, 63(Suppl S1), S16.

Barth, M. J., Chu, Y., Hanley, P. J., & Cairo, M. S. (2016). Immunotherapeutic approaches for the treatment of childhood, adolescent and young adult non-Hodgkin lymphoma. British Journal of Haematology, 173(4), 597-616. doi:10.1111/bjh.14078

Boyiadzis, M., Bishop, M. R., Abonour, R., Anderson, K. C., Ansell, S. M., Avigan, D., . . . Cairo, M. (2016). The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: Multiple myeloma, lymphoma, and acute leukemia. Journal for Immunotherapy of Cancer, 4, 90. doi:10.1186/s40425-016-0188-z

Cairo, M. S., & Pinkerton, R. (2016). Childhood, adolescent and young adult non-Hodgkin lymphoma: State of the science. British Journal of Haematology, 173(4), 507-530. doi:10.1111/bjh.14035

Cairo, M. S., Talano, J. M., Moore, T. B., Weinberg, R., Keever-Taylor, C. A., Braniecki, S., . . . Abikoff, C., (2016). Familial haploidentical (FHI) allogeneic stem cell transplantation utilizing CD34 enrichment and T cell addback in children, adolescents & adults with high-risk sickle cell disease. rapid engraftment, low incidence of AGVHD, and sustained donor chimerism. Biology of Blood and Marrow Transplantation, 22(3), S367-S368.

Cairo, M. S., Tarek, N., Lee, D. A., & Delaney, C. (2016). Cellular engineering and therapy in combination with cord blood allografting in pediatric recipients. Bone Marrow Transplantation, 51(1), 27-33. doi:10.1038/bmt.2015.196

Chu, Y., Brand, P., Morris, E., Lee, F., Talano, J. M., Shenoy, S., . . . Cairo, M. S. (2016). Natural killer cell reconstitution following familial haploidentical (FHI) CD34 enriched stem cell transplantation with T-cell add back in patients with high risk sickle cell disease (SCD) (IND 14359). Biology of Blood and Marrow Transplantation, 22(3), S151-S152. doi:10.1016/j.bbmt.2015.11.502

Chu, Y., Flower, A., & Cairo, M. S. (2016). Modification of expanded NK cells with chimeric antigen receptor mRNA for adoptive cellular therapy. Methods in Molecular Biology, 1441, 215-230. doi:10.1007/978-1-4939-3684-7_18

Chu, Y., Lee, F., Ayello, J., Hang, B., Zhang, M., Wong, H., . . . Cairo, M. (2016). Therapeutic effects of Alt-803, an IL-15 superagonist, in combination with anti-CD20 chimeric antigen receptor modified expanded natural killer cells against Burkitt lymphoma (BL). Cytotherapy, 18(6), S59. doi:10.1016/j.jcyt.2016.03.194

Chu, Y., Lee, F., Ayello, J., Hang, B., Zhang, M., Wong, H., . . . Cairo, M. S. (2016). Therapeutic effects of Alt-803, an IL-15 superagonist, in combination with anti-CD20 chimeric antigen receptor modified expanded natural killer cells against Burkitt lymphoma (BL). Biology of Blood and Marrow Transplantation, 22(3), S151. doi:10.1016/j.bbmt.2015.11.501

Chu, Y., Lee, F., Hamby, C., Misarti, J., Hang, B., Ayello, J., . . . Cairo, M. (2016). Regulation of cytokine release and anti-tumor effect of anti-CD20 CAR modified expanded natural killer cells by Alt-803, an IL-15 superagonist. Experimental Hematology, 44(9), S64. doi:10.1016/j.exphem.2016.06.107

Chu, Y., Yahr, A., Cheng, B., Hang, B., Ayello, J., Barth, M., & Cairo, M. S. (2016). Enhanced in-vitro and in-vivo targeting of rituximab sensitive and resistant Burkitt lymphoma (BL) by anti-CD20 chimeric antigen receptor (CAR) modified expanded natural killer cells in combination with a histone deacetylase inhibitor, romidepsin. Biology of Blood and Marrow Transplantation, 22(3), S392. doi:10.1016/j.bbmt.2015.11.915

Chu, Y., Yahr, A., Cheng, B., Hang, B., Ayello, J., Barth, M., & Cairo, M. S. (2016). Enhanced in-vitro and in-vivo targeting of rituximab sensitive and resistant Burkitt lymphoma (BL) by anti-CD20 chimeric antigen receptor (CAR) modified expanded natural killer cells in combination with a histone deacetylase inhibitor, romidepsin. Pediatric Blood & Cancer, 63(Suppl S1), S96.

Fenske, T. S., Ahn, K. W., Graff, T. M., DiGilio, A., Bashir, Q., Kamble, R. T., . . . Cairo, M. (2016). Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation. British Journal of Haematology, 174(2), 235-248. doi:10.1111/bjh.14046

Flower, A., Chu, Y., Ayello, J., Kurtzberg, J., Lee, D., & Cairo, M. S. (2016). Ex-vivo expansion of previously cryopreserved, thawed and re-cryopreserved cord blood mononuclear cells (CBMC) utilizing K562-mbIL21-41BBL; potential for adoptive cellular immunotherapy post umbilical cord blood transplantation (UCBT). Biology of Blood and Marrow Transplantation, 22(3), S153. doi:10.1016/j.bbmt.2015.11.504

Ghersin, Z., Harrison, L., Abrams, D.,  Fabricatore, S., Militano, O., Van de Ven, C., . . . Cairo, M. S. (2016). Low molecular weight heparin (LMWH) prophylaxis to prevent sinusoidal obstructive syndrome (SOS) in pediatric hematopoietic stem cell transplant (HSCT) recipients. Biology of Blood and Marrow Transplantation, 22(3), S289-S290. doi:10.1016/j.bbmt.2015.11.743

Hamill, D., Baxter-Lowe, L. A., Shenoy, S., Moore, T. B., Morris, E., Abikoff, C., . . . Cairo, M. S. (2016). Robust donor chimerism and engraftment following familial haploidentical (FHI) (CD34 enriched and T-cell addback) allogeneic stem cell transplantation in patients with high risk sickle cell disease (SCD). Biology of Blood and Marrow Transplantation, 22(3), S95-S96. doi:10.1016/j.bbmt.2015.11.396

Hochberg, J., Harrison, L., Morris, E., Militano, O., Brand, P., Fabricatore, S., . . . Cairo, M. S.. (2016). Safety of liposomal cytarabine CNS prophylaxis in children, adolescent and young adult hematopoietic stem cell transplant recipients with acute leukemia and non-Hodgkin lymphoma. Bone Marrow Transplantation, 51(9), 1249-1252. doi:10.1038/bmt.2016.100

Hochberg, J., Harrison, L., Morris, E., Militano, O., Brand, P., Fabricatore, S., . . . Cairo, M. S. (2016). Safety of liposomal cytarabine CNS prophylaxis in children, adolescent and young adult hematopoietic stem cell transplant recipients with acute leukemia and non-hodgkin lymphoma. Bone Marrow Transplantation, 51(9), 1249-1252.  doi:10.1038/bmt.2016.100